Can low androgen availability in women be linked to reduced energy and well-being?

Low energy and reduced well-being are common, clinically important symptoms in women, but current evidence does not support diagnosing an androgen-deficiency syndrome—or assigning causation—on the basis of testosterone testing alone.

Association with energy and well-being

• Observational evidence provides only a weak, non-causal signal. In a community study of 1,224 women, endogenous androgen measures were generally not independently associated with psychological well-being.
• A limited exception was a positive association between DHEAS and vitality among premenopausal women; this finding requires replication. In midlife cohorts, testosterone, SHBG, and calculated free-androgen index showed only weak associations with well-being and physical-function symptoms.
• These findings cannot establish whether androgen status causes symptoms or instead tracks with other health, behavioral, or medical factors. Postpartum data similarly did not find significant associations of total testosterone with fatigue or vigor.

Diagnostic and measurement implications

• Professional guidance finds no validated female serum-testosterone threshold that defines androgen deficiency or predicts fatigue, vitality, mood, or quality of life.
• Fatigue and diminished well-being are nonspecific and do not reliably correlate with serum testosterone. Thus, even a result considered “low” does not establish that androgen availability is the cause.
• Measurement is an additional limitation: direct total- and free-testosterone immunoassays are highly unreliable at the low concentrations typical in women. LC-MS/MS improves analytical accuracy for total testosterone, but does not create a diagnostic cutoff or demonstrate symptom causation.

Clinical implications

• Reduced energy or well-being warrants assessment for more established contributors, including depression, sleep disruption, anemia, thyroid disease, medication effects, and comorbidity.
• Testosterone is not evidence-based treatment for general well-being, mood, or fatigue; its evidence-supported use is limited to carefully assessed postmenopausal women with hypoactive sexual desire disorder.

Bottom line

• Low androgen availability may be associated with lower vitality in some women, but the association is uncertain and non-causal; serum testosterone alone cannot diagnose androgen deficiency or explain reduced energy and well-being.